Contact
Danolyte Global LLC.
Corporate Headquarters
Marketing Office USA and Canada
Marketing@DanolyteGlobal.com
Accounting Office
Accounting@DanolyteGlobal.com
Corporate Leadership
John T. Julian, CEO
JohnJ@DanolyteGlobal.com
913-489-7600
John T. Julian Jr., President
Johntj@DanolyteGlobal.com
913-489-7600
Paul K. Thoma, General Counsel
PaulT@DanolyteGlobal.com
913-489-7600
Jay P. Julian, VP Operations
JayP@DanolyteGlobal.com
913-492-7800
Contact
Virus Update
Danolyte has demonstrated effectiveness against viruses similar to SARS-CoV-2 on hard porous and/or non-porous surfaces. Therefore, Danolyte can be used against SARS-CoV-2 when used in accordance with the directions for use against Adenovirus Type 1, on hard, porous/non-porous surfaces. Refer to the CDC website at www.cdc.gov/outbreaks or OEI website at https://www.oie for additional information.
Corporate Headquarters
Marketing Office USA and Canada
Accounting Office
Corporate Leadership